hydroxyproline has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Excerpt | Relevance | Reference |
---|---|---|
"Pancreatic cancer is notorious for its poor prognosis." | 1.43 | Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2. ( Cabral, H; Iwata, C; Kano, MR; Miyazono, K; Morishita, Y; Sakai, S; Tanaka, HY, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sakai, S | 1 |
Iwata, C | 1 |
Tanaka, HY | 1 |
Cabral, H | 1 |
Morishita, Y | 1 |
Miyazono, K | 1 |
Kano, MR | 1 |
1 other study available for hydroxyproline and Carcinoma, Ductal, Pancreatic
Article | Year |
---|---|
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
Topics: Albumin-Bound Paclitaxel; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, T | 2016 |